glp 1 zepbound Weight-Loss Drug Is Being Tested as a Treatment for Long Covid Zepbound Vials Online | Zepbound

C.KlufasM

While some physicians are prescribing these medications for their approved uses of treating type 2 diabetes, obesity and obstructive sleep apnea, others are frequently making off-label prescriptions

The most commonly reported adverse events were nausea, diarrhea, and vomiting

The weight loss ranges of the two treatment groups were -6.9 kg (-7%) and -9.7 kg (-9.6%), respectively

Scott Butsch, director of obesity medicine at the Cleveland Clinic Bariatric and Metabolic Institute

This changed significantly with the approval of Wegovy for heart disease in patients with obesity, as this allows Medicare to make patients eligible for the drug